CGF Holdings Makes Strategic Investment in MediPro Direct, Marking a Return to the Mobile Diagnostics Market
CGF Holdings Makes Strategic Investment in MediPro Direct, Marking a Return to the Mobile Diagnostics Market
PR Newswire
KANSAS CITY, Mo., Sept. 16, 2026
KANSAS CITY, Mo., Sept. 16, 2026 /PRNewswire/ -- CGF Holdings announced a strategic investment in MediPro Direct, a nationwide provider of mobile diagnostics services. The partnership brings the Grant family back into the diagnostics services space, an industry in which the family has deep historical roots, and positions MediPro Direct for its next phase of growth.
Founded in 2006, MediPro Direct connects clinical trial sponsors, life insurers, pharmaceutical companies, specialty labs, senior care, and healthcare organizations with a nationwide network of more than 15,000 background-checked, experienced mobile medical providers. Through its proprietary Quality First rating system and innovative case management software, MediPro Direct coordinates specimen collection, health screenings, paramedical examinations, and related services across all 50 states, with a focus on reliability, professionalism, and exceptional patient experience. The company's stated mission centers on connecting essential medical and genetic services with the most efficient, professional delivery network in the industry, in service of improving outcomes for the millions of patients and organizations it touches.
"We're excited to be back in the diagnostics services space," said Joey Grant, Managing Partner of CGF Holdings. "Our family has a long history in this industry, and MediPro Direct's team, network, technology, and reputation for exceptional quality make it exactly the kind of platform we want to partner with."
"The CGF team brings operating experience and a strategic understanding of this industry to the table," said Ryan Janeway, CEO of MediPro Direct. "With the rising demand for home-based services, the mobile market is growing rapidly. This partnership will help MediPro expand its provider network, enhance its technology platform, and pursue new partnerships across the clinical trial, life insurance, specialty lab, senior care, and wellness markets it serves today."
Media Contact:
Kendall Thurlow
kendall.thurlow@cgfholdingsco.com
SOURCE CGF Holdings
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
What’s Ahead for Stocks This Quarter—and Where to Invest
Are TIPS ETFs the Best Way to Fight Inflation?
10 Best Blue-Chip Stocks to Buy for the Long Term
This 1-Star Stock Trades at a 94% Premium. Is It Time to Sell?
United States